Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol. Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse. Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase. Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, plasma corticosterone levels in Crhr1 KO mice were significantly less than those of WT mice after forced-swim stress (15).”
From Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) · cites this paper as [15]
In the citing paper
“CRF 1 overexpression results in an anxiogenic-and depressive-like profile in rodents and humans [342][343][344][345][346].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [343]
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Chalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478
Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Cited by
Items 601–700 of 1,000
Sanchez, R. L., Reddy, A. P., & Bethea, C. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.059 · Cited by 21
“…of the CRF-R1 and CRF-R2 receptors is distinct and implies diverse physiological functions, as evidenced by the divergent phenotypes of CRF-R1- and CRFR2-null mice (Smith et al., 1998; Timpl et al., 1998; Muller et al., 2003; Keck et al., 2005; Refojo et al., 2005; Pastor et al., 2008).”
BackgroundMouse anxiety: the power of knockout
Lesch, K. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500016 · Cited by 22
Nakayama, T., Shimmura, T., Shinomiya, A., Okimura, K., Takehana, Y., Furukawa, Y., Shimo, T., Senga, T., Nakatsukasa, M., Nishimura, T., et al. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-019-0866-6 · Cited by 22
Tsartsali, L., Papadopoulos, M., Lagona, E., Papadimitriou, A., Kanaka‐Gantenbein, C., Louizou, E., Kastania, A., Priftis, K. Ν., & Chrousos, G. P. (2012) · NeuroImmunoModulation · doi:10.1159/000329592 · Cited by 22
Post, A., Ohl, F., Almeida, O. F. X., Binder, E. B., Rücker, M., Welt, S., Binder, E., Holsboer, F., & Sillaber, I. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2134-x · Cited by 22
“The dark/light box consists of a dark compartment and a white compartment (additionally illuminated, 680–700 lx), which are connected by a tunnel (see Timpl et al. 1998).”
BackgroundSelf-citationBowers, L. K., Swisher, C. B., & Behbehani, M. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02886-5 · Cited by 22
N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders
Keays, D. A., & Nolan, P. M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.107 · Cited by 22
Radulović, J., Blank, T., Eckart, K., Radulović, M., Stiedl, O., & Spiess, J. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-49421-8_4 · Cited by 22
Viggiano, A., Cacciola, G., Widmer, D. A. J., & Viggiano, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.032 · Cited by 21
Bertagna, N. B., dos Santos, P. G. C., Queiroz, R. M., Fernandes, G. J. D., Cruz, F. C., & Miguel, T. T. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00182-3 · Cited by 21
A Polymorphism in the Crhr1 Gene Determines Stress Vulnerability in Male Mice
Labermaier, C., Kohl, C., Hartmann, J., Devigny, C., Altmann, A., Weber, P. C., Arloth, J., Quast, C., Wagner, K. V., Scharf, S. H., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1986 · Cited by 21
Self-citationWhat can HPA axis-linked genes tell us about anxiety disorders in adolescents?
Bortoluzzi, A., Blaya, C., da Rosa, E. D., Paim, M. F., Rosa, V. D. O., Leistner‐Segal, S., & Manfro, G. G. (2015) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2015-0035 · Cited by 21
Stork, O., Kojima, N., Stork, S., Kume, N., & Obata, K. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00400-x · Cited by 21
Tochigi, M., Kato, C., Otowa, T., Hibino, H., Marui, T., Ohtani, T., Umekage, T., Kato, N., & Sasaki, T. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01541.x · Cited by 21
Sotnikov, S., Chekmareva, N. Y., Schmid, B., Harbich, D., Malik, V. A., Bauer, S., Kühne, C., Markt, P. O., Deussing, J. M., Schmidt, M. V., et al. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12624 · Cited by 20
“…was shown to be critical in the regulation of anxiety-related behavior (Heinrichs et al., 1997; Holsboer, 1999; Zorrilla & Koob, 2004; Sztainberg et al., 2010), and mice deficient in Crhr1 exhibit decreased anxiety (Smith et al., 1998; Timpl et al., 1998; M€uller et al., 2003; Refojo et al., 2011).”
BackgroundFukushiro, D. F., Saito, L. P., Mári-Kawamoto, E., Aramini, T. C. F., Costa, J. M., Josino, F. S., Uehara, R. A., & Frussa‐Filho, R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.013 · Cited by 20
“…context, anxiogenic-like effects of Eth withdrawal have been observed up to 48 h after the removal of Eth and had returned to control levels by 96 h in mice subjected to the light/dark box test (Barnes et al., 1990; Costall et al., 1988, 1990, 1991, 1993; Timpl et al., 1998; Wallis et al., 1995).”
From neural to genetic substrates of panic disorder: Insights from human and mouse studies
Santos, M., D’Amico, D., & Dierssen, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.039 · Cited by 20
Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse
Martin, N. M., Small, C. J., Sajedi, A., Liao, X. H., Weiss, R. E., Gardiner, J., Ghatei, M. A., & Bloom, S. R. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.012 · Cited by 20
Takahashi, Y., Hashizume, M., Shin, K., Terauchi, T., Takeda, K., Hibi, S., Murata-Tai, K., Fujisawa, M., Shikata, K., Taguchi, R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300864p · Cited by 20
Diagnose und Klinik der Fibromyalgie
Conrad, I. (2003) · Der Schmerz · doi:10.1007/s00482-003-0271-5 · Cited by 20
Murakami, I., Takeuchi, S., Kudo, T., Sutou, S., & Takahashi, S. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0143 · Cited by 20
“CRH binds to its specific receptor, CRH-R1 (Vita et al. 1993, Timpl et al. 1998), stimulating the accumulation of intracellular cAMP levels (Giguere et al. 1982, Aguilera et al. 1983, Litvin et al. 1984, Vita et al. 1993, Grammatopoulos & Chrousos 2002), which is followed by the activation of…”
Pournajafi‐Nazarloo, H., Nishiyama, M., Tanaka, Y., Asaba, K., & Hashimoto, K. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00006-x · Cited by 20
Wan, Y., Zhang, Z., Lin, D., Wang, X., Huang, T., Su, J., Zhang, J., Li, J., & Wang, Y. (2022) · Genes · doi:10.3390/genes13101680 · Cited by 19
García‐Pérez, D., Ferenczi, S., Kovács, K., Laorden, M. L., Milanés, M. V., & Núñez, C. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.09.020 · Cited by 19
Conti, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.016 · Cited by 19
“Further, CRF overexpressing mice show more anxiety-like behavior (van Gaalen et al., 2002; Stenzel-Poore et al., 1994), and CRF1 receptor knockout (KO) mice show less anxiety-like behavior than wild type (WT) mice (Contarino et al., 1999; Smith et al., 1998; Timpl et al., 1998).”
BackgroundTherapeutics for depression and anxiety disorders
Holsboer, F. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.08.012 · Cited by 19
Self-citationYang, M., Farrokhi, C. B., Vasconcellos, A., Blanchard, R. J., & Blanchard, D. C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.013 · Cited by 19
“Mice deficient for CRF1 exhibited reduced anxiety-like behaviors [46].”
BackgroundSuicide: Allostatic regulation and resilience
Stacy, M. A., & Schulkin, J. A. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105691 · Cited by 18
Boero, G., Tyler, R. E., O’Buckley, T. K., Balan, I. S., Besheer, J., & Morrow, A. L. (2022) · Biomolecules · doi:10.3390/biom12081134 · Cited by 18
“CRFR1 mediates the activation of the HPA axis [11,28] and its activation induces anxiety-like behavior [29].”
BackgroundShao, M., Yuan, F., Liu, J., & Luo, H. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s383812 · Cited by 18
“Mice deficient for CRHR1 display a severe impairment of stressinduced ACTH release from pituitary corticotropes, marked glucocorticoid deficiency, impaired stress response and significantly reduced anxiety-like behavior.(44,45) CRHR2-mutant mice are hypersensitive to stress and display increased anxiety-like behaviour.”
BackgroundCriscio, M. D., Lodahl, J. E., Stamatakis, A., Kitraki, E., Bakoyiannis, I., Repouskou, A., Bornehag, C., Gennings, C., Lupu, D., & Rüegg, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.137633 · Cited by 18
“Mice lacking Crhr1 have been observed to have impaired endocrine response to stress and decreased anxiety-like behavior (Timpl et al., 1998; Smith et al., 1998).”
Neuropeptide Regulation of Stress-Induced Behavior
Sztainberg, Y., & Chen, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10015-0 · Cited by 18
“Mice deficient for CRFR1 (CRFR1-KO) display a disrupted HPA axis activation in response to stress, causing glucocorticoid deficiency.(177,178) However, basal plasma ACTH was found to be similar to that in wild-type controls, probably due to the action of AVP.”
BackgroundMethodSaavedra, J. M., & Pavel, J. (2005) · Drug Development Research · doi:10.1002/ddr.20027 · Cited by 18
Punn, A., Chen, J., Delidaki, M., Tang, J., Liapakis, G., Lehnert, H., Levine, M. A., & Grammatopoulos, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272161 · Cited by 18
Mutschler, J., Bilbao, A., von der Goltz, C., Demiralay, C., Jahn, H., Wiedemann, K., Spanagel, R., & Kiefer, F. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp065 · Cited by 18
“A similar habituation procedure has been reported elsewhere (Spanagel et al., 1996; Timpl et al., 1998)”
MethodSelf-citationCorticotropin-releasing Factor 2 Receptor Localization in Skeletal Muscle
Samuelsson, S. J., Lange, J. S., Hinkle, R. T., Tarnopolsky, M. A., & Isfort, R. J. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6279.2004 · Cited by 18
“…an impaired food intake reduction after stimulation with urocortin I, lack of vasodilatation after stimulation with urocortin I, a normal stress response, and postnatal hypervasculatization (Smith et al. 1998; Timpl et al. 1998; Bale et al. 2000,2002; Coste et al. 2000; Kishimoto et al.”
BackgroundDahl, J. P., Doyle, G. A. R., OSLIN, D., Buono, R. J., Ferraro, T. N., Lohoff, F. W., & Berrettini, W. H. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.12.004 · Cited by 18
Heuser, I. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_8 · Cited by 18
Borrelli, E. (1998) · Nature Genetics · doi:10.1038/452 · Cited by 18
Advanced Transgenic Approaches to Understand Alcohol-Related Phenotypes in Animals
Bilbao, A. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_204 · Cited by 17
“These models include two global CRF1 receptor mutants, developed by two different labs (Smith et al. 1998; Timpl et al. 1998), one conditional brain-specific CRF1 receptor mutant (and thus, extra HPA axis deletion, Schmidt et al. 2006), one CRF2 receptor mutant (Coste et al. 2000), and two CRF…”
BackgroundMethodStem Cells in Neuroendocrinology
Pfaff, D., & Christen, Y. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8 · Cited by 17
da Silva, B. S., Rovaris, D. L., Schuch, J. B., Mota, N. R., Cupertino, R. B., Aroche, A. P., Bertuzzi, G. P., Karam, R. G., Vitola, E. S., Tovo‐Rodrigues, L., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.008 · Cited by 17
Metabolic Association between Leptin and the Corticotropin Releasing Hormone
Gioldasi, S., Karvela, A., Gil, A. P. R., Rodi, M., de Lastic, A.-L., Θωμάς, Ι., Spiliotis, B. E., & Mouzaki, Α. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190206165626 · Cited by 17
Heydendael, W., Sengupta, A., & Bhatnagar, S. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.09.002 · Cited by 17
“Work using Crhr1 knock-out mice has shown a reduction in anxietyrelated behavior in the knock-out mice when compared to wild-type controls (Smith et al., 1998; Timpl et al., 1998).”
MethodCardiac dynamics in corticotropin-releasing factor receptor subtype-2 deficient mice
Stiedl, O., & Meyer, M. (2003) · Neuropeptides · doi:10.1016/s0143-4179(02)00135-x · Cited by 17
Schmidt, M. V., Oitzl, M. S., Steenbergen, P. J., Lachize, S., Wurst, W., Müller, M. B., de Kloet, E. R., & Meijer, O. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.023 · Cited by 17
Self-citationIsogawa, K., Akiyoshi, J., Tsutsumi, T., Kodama, K., Horinouti, Y., & Nagayama, H. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174004 · Cited by 17
“CRF-R1 deficiency also leads to anxiolytic-like effects in mouse mutants exploring a light/dark box paradigm (Timpl et al., 1998), a related dark/light emergence task, or an elevated plusmaze (Smith et al., 1998).”
BackgroundThe CRF 1 receptor mediates social behavior deficits induced by opiate withdrawal
Piccin, A., & Contarino, A. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24697 · Cited by 16
“…not show the typical circadian rise of plasma corticosterone and lack plasma corticosterone and adrenocorticotropic hormone (ACTH) responses to stressful events, including the stress of substance withdrawal (Contarino & Papaleo, 2005; Papaleo et al., 2007; Smith et al., 1998; Timpl et al., 1998).”
BackgroundLodge, N. J., Li, Y.-W., Chin, F. T., Dischino, D. D., Zoghbi, S. S., Deskus, J. A., Mattson, R. J., Imaizumi, M., Pieschl, R. L., Molski, T. F. P., et al. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.03.005 · Cited by 16
“CRF1 receptor deletion in mice results in decreased anxiety-like behavior and a reduced HPA axis response to stress [6].”
BackgroundPrenatal stress, anxiety and depression: a mechanism involving CRH peptide family.
Fan, J., Chen, X., & Du, J.-Z. (2014) · PubMed · Cited by 16
Raineki, C., Ellis, L. A., & Weinberg, J. (2017) · Hippocampus · doi:10.1002/hipo.22823 · Cited by 17
“…of the CRH system is associated with reductions in anxiety-like behavior, as shown in studies using CRHR1-deficient mice (Smith et al., 1998; Timpl et al., 1998), conditional inactivation of the CRHR1 in limbic areas (M€uller et al., 2003), and CRHR1 antagonism in rats (Keck et al., 2001;…”
Regulation of anxiety-like behavior and Crhr1 expression in the basolateral amygdala by LMO3
Savarese, A. M., & Lasek, A. W. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.03.016 · Cited by 16
“Mice lacking the Crhr1 gene show a decreased anxiety-like phenotype (Contarino et al., 1999; Muller et al., 2003; Smith et al., 1998; Timpl et al., 1998), and CRHR1 antagonists administered systemically (Zorrilla et al.”
BackgroundInfluentialHypothalamic-Pituitary-Adrenal Axis in Gastrointestinal Physiology
Fukudo, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00028-2 · Cited by 17
Miguel, T. T., Gomes, K. S., & Nunes‐de‐Souza, R. L. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500043 · Cited by 16
Family environment interacts with CRHR1 rs17689918 to predict mental health and behavioral outcomes
Roy, A., Laas, K., Kurrikoff, T., Reif, A., Veidebaum, T., Lesch, K., & Harro, J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.004 · Cited by 16
“Crhr1 expression, especially in the limbic system, is involved in stress responses and underlies the development of anxiety-like behavior in rodents (Müller et al., 2003; Preil et al., 2001; Timpl et al., 1998).”
Natriuretic peptides and panic disorder: therapeutic prospects
Kellner, M. B., Jahn, H., & Wiedemann, K. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.3.381 · Cited by 16
Stress, corticotropin-releasing factor and serotonergic neurotransmission
Linthorst, A. C. E. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80028-8 · Cited by 16
Melanocortin and leptin signaling systems: Central regulation of catabolic energy balance
Fisher, S. L., Yagaloff, K. A., & Burn, P. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036646 · Cited by 16
Stress Neurobiology and Developmental Psychopathology
Jacoby, N., Overfeld, J., Binder, E. B., & Heim, C. M. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy221 · Cited by 16
Wan, H., & Chen, Y. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.1.d · Cited by 15
Wang, X., Sun, Y., Fu, M., Chen, P., Wang, Q., Hua, J., Fu, K., Zhang, W., Zhu, L., Yang, L., et al. (2022) · Frontiers in Environmental Science · doi:10.3389/fenvs.2022.860786 · Cited by 15
Schmidt, M. V., & Müller, M. B. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.11.002 · Cited by 15
Pournajafi‐Nazarloo, H., Tanaka, Y., Dorobanţu, M., & Hashimoto, K. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00150-2 · Cited by 15
Small molecule corticotropin-releasing factor antagonists
Lanier, M. C., & Williams, J. P. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.11.1619 · Cited by 15
“Transgenic CRF1 knockout mice are less anxious [3] whereas animals lacking the CRF2 receptor are hypersensitive to stress, display increased anxiety-like behaviour and demonstrate reduced food intake when stressed [4].”
BackgroundCan CRF1 receptor antagonists become antidepressant and/or anxiolytic agents?
Overstreet, D. H., Knapp, D. J., & Breese, G. R. (2005) · Drug Development Research · doi:10.1002/ddr.20023 · Cited by 15
“Mice without the CRF1 receptor display less anxiety-like behavior after exposure to stress [Timpl et al., 1998; Weninger et al., 1999].”
Hermann, B., Landgraf, R., Keck, M. E., Wigger, A., Morrow, A. L., Ströhle, A., Holsboer, F., & Rupprecht, R. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150581 · Cited by 15
Self-citationPryce, C. R., & Klaus, F. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.003 · Cited by 14
“The KO mice exhibited increased locomotor activity in an open field (Timpl et al., 1998) or no change in locomotor activity in an open field (Smith et al., 1998), relative to WT and HET mice.”
InfluentialPentkowski, N. S., Tovote, P., Zavala, A. R., Litvin, Y., Blanchard, D. C., Spiess, J., & Blanchard, R. J. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.06.008 · Cited by 14
“In particular, gene deletion experiments indicate that anxiety-like defensive behaviors are potentiated principally through CRF1 (Smith et al., 1998; Timpl et al., 1998) and reduced via CRF2 (Bale et al.”
Genetic Dissection of the Neuroendocrine and Behavioral Responses to Stressful Challenges
Chen, A. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8_6 · Cited by 14
“Furthermore, CRFR1 knock-out mice displayed reduced anxiety-like behavior (Smith et al. 1998; Timpl et al. 1998; Contarino et al. 1999; Muller et al. 2003).”
Yoshida, S., Ohnishi, R., Tsuneoka, Y., Yuka, Y.-M., Muramatsu, R., Kato, T., Funato, H., & Kuroda, K. O. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00204 · Cited by 14
“This anxiogenic effects of CRF have been attributed to the activation of corticotropin-releasing factor receptor 1 (CRFR1), as evidenced by CRFR1 blockade or genetic targeting studies (Timpl et al., 1998), while the role of CRFR2 might be recovery from stress.”
BackgroundMolekulare Grundlagen der Adipositas
Hebebrand, J., Hinney, A., & Oeffner, F. (2001) · Springer eBooks · doi:10.1007/978-3-642-56858-9_12 · Cited by 14
Silberstein, S., Vogl, A. M., Bonfiglio, J. J., Wurst, W., Holsboer, F., ARZT, E. S., Deussing, J. M., & Refojo, D. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03967.x · Cited by 14
Self-citationSzarek, E., Zimbardi, K., McMillen, I. C., Young, I. R., Houghton, D., & Schwartz, J. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.141523 · Cited by 14
Gutman, D. A., Coyer, M. J., Boss-Williams, K. A., Owens, M. J., Nemeroff, C. B., & Weiss, J. M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.05.003 · Cited by 14
The Hypothalamic-Pituitary-Adrenal Axis in Fibromyalgia: Where Are We in 2001?
Crofford, L. J. (2002) · Journal of Musculoskeletal Pain · doi:10.1300/j094v10n01_17 · Cited by 14
“Mice genetically engineered to eliminate expression of CRHR1 have an impaired stress response and reduced anxiety related behaviors (8,9).”
BackgroundGenetic dissection of anxiety in autoimmune disease
Nakamura, K., Xiu, Y., Ohtsuji, M., Sugita, G., Abe, M., Ohtsuji, N., Hamano, Y., Jiang, Y., Takahashi, N., Shirai, T., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg128 · Cited by 14
Stiedl, O., & Meyer, M. (2002) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02734251 · Cited by 14
Schrandt, M. N., & Lema, S. C. (2011) · Marine Ecology Progress Series · doi:10.3354/meps09411 · Cited by 13
“CRH-R1 regulates HPA/HPI responses to stress (Timpl et al. 1998) whereas, in mammals at least, CRH-R2 appears to fine tune longer-term changes in stress-coping be - haviors (Dautzenberg et al. 2001).”
BackgroundSilberstein, S., Vogl, A. M., Refojo, D., Senin, S. A., Wurst, W., Holsboer, F., Deussing, J. M., & ARZT, E. S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.014 · Cited by 13
Self-citationMällo, T., Berggård, C., Eller, M., Damberg, M., Oreland, L., & Harro, J. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.02.016 · Cited by 13
Dissecting Adrenal and Behavioral Responses to Stress by Targeted Gene Inactivation in Mice
Brewer, J. A., Bethin, K. E., Schaefer, M. L., Muglia, L. M., Vogt, S. K., Weninger, S. C., Majzoub, J. A., & Muglia, L. J. (2003) · Stress · doi:10.1080/1025389031000116460 · Cited by 13
“The recent findings that, in addition to CRH, several CRH-like molecules are synthesized in the brain (Dautzenberg and Hauger, 2002), together with the evidence that both CRH receptor-1 and -2 KO mice (Timpl et al., 1998; Coste et al., 2001) and CRH KO mice treated with antagonists (Weninger et al.”
BackgroundRoles for corticotropin-releasing factor receptor type 1 in energy homeostasis in mice
Sakamoto, R., Matsubara, E., Nomura, M., Wang, L., Kawahara, Y., Yanase, T., Nawata, H., & Takayanagi, R. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.005 · Cited by 13
Chapter 4.1 Peptide receptor ligands to treat anxiety disorders
Steckler, T. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00010-0 · Cited by 13
Self-citationYuan, D., Wang, B., Tang, T., Luo, L., Zhou, C., Li, Z., & Li, L. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-020-00922-5 · Cited by 12
Devetzis, V., Zarogoulidis, P., Kakolyris, S., Vargemezis, V. A., & Chatzaki, Ε. (2012) · Medicinal Research Reviews · doi:10.1002/med.21268 · Cited by 12
Tovote, P., Farrokhi, C. B., Gonzales, R. M. K., Schnitzbauer, U., Blanchard, D. C., Blanchard, R. J., & Spiess, J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.12.001 · Cited by 12
Wang, Y., Chen, Z., Yang, Z.-Q., Zhang, X., Li, J., Wang, J.-J., & Zhu, J. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.05.005 · Cited by 12
Heinrichs, S. C. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80012-4 · Cited by 12
Huhman, K. L., & Jasnow, A. M. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195168761.003.0013 · Cited by 12
Structural and Functional Insights into CRF Peptides and Their Receptors
Matsoukas, M., Panagiotopoulos, V., Karageorgos, V., Chrousos, G. P., Venihaki, M., & Liapakis, G. (2024) · Biology · doi:10.3390/biology13020120 · Cited by 11
“…and depression are predominately mediated through In general, CRF 2 R acts in a manner that counteracts the effects of CRF 1 R, having anxiolytic-like effects following administration of the CRF 2 R-selective UcnII or UcnIII in experimental animals [44–46]. its interaction with CRF 1 R [15,38–40].”
InfluentialYang, X., & Geng, F. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25238 · Cited by 11
HPA Axis Modulation in the Treatment of Mood Disorders
Lauren, B., & Charles, B. (2013) · InTech eBooks · doi:10.5772/51600 · Cited by 11
The Impact of Stress on Serotonergic Neurotransmission
Linthorst, A. C. E., & Reul, J. M. H. M. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70097-7 · Cited by 11
Self-citationEvaluation of Alcohol Preference and Drinking in msP Rats Bearing a Crhr1 Promoter Polymorphism
Logrip, M. L., Walker, J. R., Ayanwuyi, L. O., Sabino, V., Ciccocioppo, R., Koob, G. F., & Zorrilla, E. P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00028 · Cited by 11
“While these studies only include male subjects, it should be noted that sex differences in CRF1 signaling have been reported in the locus coeruleus (37) that might increase female responsiveness to conditions of altered CRF1 expression, although sex differences were not observed following germline Crhr1 deletion (38).”
BackgroundReul, J. M. H. M., & Droste, S. K. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80009-4 · Cited by 11
Self-citationHypothalamic CRH neurons: A crossroad between stress and metabolism
Jiang, Z., & Tong, Q. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100384 · Cited by 10
Natriuretic peptides appeared after their receptors in vertebrates
Grandchamp, A., Tahir, S., & Monget, P. (2019) · BMC Evolutionary Biology · doi:10.1186/s12862-019-1517-x · Cited by 10
“In the mosquito, the natriuretic peptide involved in sodium regulation is the Mosquito natriuretic peptide [32], which is an ortholog of vertebrate CRF (Corticotropin Releasing Hormone), [33], involved in stress response [34].”
BackgroundNakaya, K., Nagura, Y., Hasegawa, R., Ito, H., & Fukudo, S. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15190 · Cited by 10
Terada, Y., Ohashi, H., Otani, Y., Tokunaga, K., & Takenaka, A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001889 · Cited by 10
McEvoy, P. M., Carleton, R. N., Correa, K. A., Shankman, S. A., & Shihata, S. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108140416.008 · Cited by 11
Metadata
- Authors
- Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Wurst, Wolfgang
- Venue
- Nature Genetics
- Published
- 1998-06
- Volume
- 19
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/520
- OpenAlex
- W1572525448
- Semantic Scholar
- 963e2500bc129b9bfedf1ae198ec17a73626fcdc
- Cited by
- 919
- References
- 32
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 20 · 2018: 23 · 2017: 20 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 47
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Site cant be reached (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- corticotropin-releasing hormone receptor 1, stress response, anxiety-like behavior, ACTH, corticosterone, alcohol withdrawal, exploratory activity, CRH receptor 2, adenylate cyclase
- MeSH terms
- CRF Receptor, Type 1, Adrenocorticotropic Hormone, Ethanol, Animals, Anxiety, Cells, Cultured, Corticosterone, Pituitary Gland, Stress, Physiological, Substance Withdrawal Syndrome, In Situ Hybridization, Receptors, Corticotropin-Releasing Hormone, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.